SALT LAKE CITY, July 20, 2023 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is hosting a booth at the American Association for Clinical Chemistry (AACC) annual meeting…Read More
CoDiagnostics Inc to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim CA
